JP2016531895A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531895A5
JP2016531895A5 JP2016520004A JP2016520004A JP2016531895A5 JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5 JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016520004 A JP2016520004 A JP 2016520004A JP 2016531895 A5 JP2016531895 A5 JP 2016531895A5
Authority
JP
Japan
Prior art keywords
conjugate
conjugate according
patient
polyethylene glycol
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520004A
Other languages
English (en)
Japanese (ja)
Other versions
JP6473145B2 (ja
JP2016531895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059146 external-priority patent/WO2015051307A1/en
Publication of JP2016531895A publication Critical patent/JP2016531895A/ja
Publication of JP2016531895A5 publication Critical patent/JP2016531895A5/ja
Application granted granted Critical
Publication of JP6473145B2 publication Critical patent/JP6473145B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520004A 2013-10-04 2014-10-03 Sn−38の徐放性コンジュゲート Active JP6473145B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887111P 2013-10-04 2013-10-04
US61/887,111 2013-10-04
PCT/US2014/059146 WO2015051307A1 (en) 2013-10-04 2014-10-03 Slow-release conjugates of sn-38

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019010029A Division JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Publications (3)

Publication Number Publication Date
JP2016531895A JP2016531895A (ja) 2016-10-13
JP2016531895A5 true JP2016531895A5 (https=) 2017-11-09
JP6473145B2 JP6473145B2 (ja) 2019-02-20

Family

ID=51871275

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016520004A Active JP6473145B2 (ja) 2013-10-04 2014-10-03 Sn−38の徐放性コンジュゲート
JP2019010029A Active JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019010029A Active JP6842479B2 (ja) 2013-10-04 2019-01-24 Sn−38の徐放性コンジュゲート

Country Status (14)

Country Link
US (2) US10016411B2 (https=)
EP (1) EP3052101B1 (https=)
JP (2) JP6473145B2 (https=)
KR (1) KR102320753B1 (https=)
CN (1) CN106061483B (https=)
AU (2) AU2014331591B2 (https=)
BR (1) BR112016007410B1 (https=)
CA (1) CA2925132C (https=)
DK (1) DK3052101T3 (https=)
ES (1) ES2759905T3 (https=)
MX (1) MX371201B (https=)
SG (2) SG10201811365RA (https=)
TW (1) TWI716342B (https=)
WO (1) WO2015051307A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3052101T3 (da) * 2013-10-04 2019-12-16 Prolynx Llc Konjugater af sn-38 med langsom frigivelse
CN107375288B (zh) * 2016-05-16 2019-08-23 博瑞生物医药(苏州)股份有限公司 多臂的聚合靶向抗癌偶联物
EP3613792B1 (en) 2017-04-21 2021-02-24 Bright Gene Bio-Medical Technology Co., Ltd. Multi-arm targeted anti-cancer conjugate
MX2020007306A (es) * 2018-01-12 2020-09-25 Prolynx Llc Tratamiento sinergico de cancer.
JP7546552B2 (ja) 2018-09-17 2024-09-06 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア ポリマーベースの高分子プロドラッグ
WO2020206358A1 (en) 2019-04-05 2020-10-08 Prolynx Llc Improved conjugation linkers
CN114615978A (zh) * 2019-08-28 2022-06-10 普罗林科斯有限责任公司 Dna损伤响应的偶联抑制剂
IL301558A (en) 2020-09-28 2023-05-01 Fundacio Inst De Recerca Biomedica Irb Barcelona Peptidic conjugates of sn38 useful in the treatment of cancer
US11976196B2 (en) * 2021-04-14 2024-05-07 Cambridge Crops, Inc. Silk packaging applications
IL315988A (en) 2022-03-28 2024-11-01 Sant Joan De Deu Hospital Peptidic water-soluble delivery system of anticancer drugs

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011042A (en) * 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
US20040176270A1 (en) * 2002-07-12 2004-09-09 Biomarin Pharmaceutical Inc. Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
EP1580216B1 (en) 2002-10-31 2014-05-14 Nippon Kayaku Kabushiki Kaisha High-molecular weight derivatives of camptothecins
US20040247624A1 (en) * 2003-06-05 2004-12-09 Unger Evan Charles Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
ES2629696T3 (es) * 2003-09-17 2017-08-14 Nektar Therapeutics Profármacos poliméricos multibrazo
US7462627B2 (en) 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
MX2009002855A (es) * 2006-09-15 2009-03-30 Enzon Pharmaceuticals Inc Profarmacos polimericos dirigidos que contienen enlazadores multifuncionales.
CA2738807A1 (en) * 2008-10-21 2010-04-29 Enzon Pharmaceuticals, Inc. Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
JP2012509469A (ja) 2008-11-18 2012-04-19 バクスター・インターナショナル・インコーポレイテッド ポリエチレングリコールサンプルの多分散度および/または分子量分布を決定する方法
WO2010138719A1 (en) 2009-05-28 2010-12-02 Mersana Therapeutics, Inc. Polyal drug conjugates comprising variable rate-releasing linkers
ME03396B (me) * 2009-11-18 2020-01-20 Nektar Therapeutics Oblici kisele soli konjugata polimer-lek
US8703907B2 (en) * 2010-05-05 2014-04-22 Prolynx Llc Controlled drug release from dendrimers
EP2566335B1 (en) 2010-05-05 2016-06-29 Prolynx Llc Controlled release of active compounds from macromolecular conjugates
JP2012000072A (ja) * 2010-06-18 2012-01-05 Japan Health Science Foundation 新規な抗フィブリン抗体
TW201215412A (en) * 2010-08-30 2012-04-16 Sun Pharma Advanced Res Co Ltd Stable pharmaceutical composition
WO2012088282A1 (en) * 2010-12-21 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
WO2013036857A1 (en) * 2011-09-07 2013-03-14 Prolynx Llc Sulfone linkers
DK3052101T3 (da) * 2013-10-04 2019-12-16 Prolynx Llc Konjugater af sn-38 med langsom frigivelse

Similar Documents

Publication Publication Date Title
JP2016531895A5 (https=)
JP2018528184A5 (https=)
JP2013542247A5 (https=)
SG11201908101YA (en) Hepatitis b virus surface antigen inhibitor
ES2365988T3 (es) Agentes inmunoestimulantes no específicos.
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
RU2018105655A (ru) Комбинированная терапия с применением липосомального иринотекана и ингибитора parp для лечения рака
JP2013510120A5 (https=)
HRP20170433T1 (hr) Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci
JP2016506916A5 (https=)
JP2015505296A5 (https=)
JP2013510123A5 (https=)
RU2013121788A (ru) Ингибиторы репликации вич
JP2010270124A5 (https=)
JP2015532295A5 (https=)
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
JP2013534248A5 (https=)
EP3356355B1 (en) Compounds and combinations for the treatment of hiv
RU2013104401A (ru) Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы
JP2017525718A5 (https=)
JP2016516074A5 (https=)
RU2017112308A (ru) Композиции и способы для лечения бессонницы
JP2019515908A5 (https=)
JP2017513809A5 (https=)
RU2017134443A (ru) Способ лечения с применением традипитанта